Brewster, NY, United States of America

Shingai Majuru

USPTO Granted Patents = 28 

 

 

Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 68(Granted Patents)


Location History:

  • Tarrytown, NY (US) (2014)
  • Mebane, NC (US) (2018 - 2019)
  • Brewster, NY (US) (2007 - 2022)

Company Filing History:


Years Active: 2007-2022

Loading Chart...
Loading Chart...
Loading Chart...
28 patents (USPTO):Explore Patents

As an AI assistant focused on innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with an article about the inventor Shingai Majuru.

Title: The Inventive Mind of Shingai Majuru: Pioneering Crystalline Polymorphic Forms

Introduction:

Shingai Majuru, a prolific inventor in Brewster, NY (US), has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 26 patents. His innovative work focuses on crystalline polymorphic forms, with his latest patents showcasing remarkable advancements in the field.

Latest Patents:

Majuru's latest patents revolve around the crystalline polymorphic forms of monosodium N-[8-(2-hydroxybenzoyl)amino] caprylate ('SNAC'). These patents include six polymorphic forms of SNAC, two hydrates, a methanol solvate, an ethanol solvate, and an amorphous form. His pioneering research in this area demonstrates a deep understanding of molecular structures and their implications in pharmaceutical development.

Career Highlights:

Throughout his career, Shingai Majuru has been associated with renowned companies such as Emisphere Technologies, Inc., and Novartis AG. His expertise and dedication have led to groundbreaking innovations that have the potential to revolutionize the pharmaceutical industry. Majuru's commitment to excellence is evident in the impact of his patents on the field of drug development.

Collaborations:

Majuru has had the privilege of working alongside esteemed colleagues such as Halina Levchik and Brahma N Singh. These collaborations have played a crucial role in advancing his research and bringing his innovative ideas to fruition. The synergy between Majuru and his coworkers has resulted in groundbreaking discoveries that have the potential to shape the future of pharmaceuticals.

Conclusion:

In conclusion, Shingai Majuru stands out as a visionary inventor whose contributions to the field of pharmaceuticals are both significant and far-reaching. His relentless pursuit of innovation and his pioneering work in crystalline polymorphic forms underscore his status as a trailblazer in the industry. As he continues to push the boundaries of scientific exploration, the impact of his inventions is poised to transform the landscape of pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…